Agenda

Return

C.44

To:	Board of Supervisors
From:	Ronald Harvey, Risk Manager
Date:	March 3, 2009

Contra

Costa

County

Subject:

AMEND Contract with Environmental & Occupational Risk Management, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 03/03/2009

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Gayle B. Uilkema, District II Supervisor
Mary N. Piepho, District III Supervisor
Susan A. Bonilla, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:

Ron Harvey, Risk Manager (335-1443)

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: March 3, 2009
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Risk Manager, or designee, to execute a contract amendment with Environmental & Occupational Risk Management, Inc. (EORM) to increase the payment limit by $30,000 to a new payment limit of $444,660 with no change in contract date. This contract is being amended to pay for additional consulting services per US Pharmacopeia (USP) 797 Monitoring Requirements.

FISCAL IMPACT:

Costs for consulting services will be funded through Health Services Department to ensure their pharmacy is in compliance with USP 797 Monitoring Requirements (100% Enterprise I Fund).

BACKGROUND:

Environmental and Occupational Risk Management, Inc. (EORM) is a consulting firm consisting of staff possessing specialized technical skills in indoor air quality. Under the contract amendment, additional services will be provided to the Health Services Pharmacy. The anticipated cost includes additional hours to cover air quality monitoring required under the new USP 797 regulation.

USP 797 refers to chapter 797 "Pharmaceutical Compounding – Sterile Preparations," the first set of enforceable sterile compounding standards issued by the United States Pharmacopeia (USP). USP 797 describes the guidelines, procedures and compliance requirements for compounding sterile preparations and sets the standards that apply to all settings in which sterile preparations are compounded.